Trial Profile
Effect of LY2216684 on the Pharmacokinetics of Theophylline in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Edivoxetine (Primary) ; Theophylline
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 15 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Dec 2010 New trial record